Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 3/2005

01-06-2005 | CASE REPORT

Anaphylactic reaction to infliximab in two rheumatoid arthritis patients who had previously received infliximab and resumed

Authors: Fumiaki Sugiura, Toshihisa Kojima, Michinari Oba, Hiroki Tsuchiya, Naoki Ishiguro

Published in: Modern Rheumatology | Issue 3/2005

Login to get access
Metadata
Title
Anaphylactic reaction to infliximab in two rheumatoid arthritis patients who had previously received infliximab and resumed
Authors
Fumiaki Sugiura
Toshihisa Kojima
Michinari Oba
Hiroki Tsuchiya
Naoki Ishiguro
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Modern Rheumatology / Issue 3/2005
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-005-0386-x

Other articles of this Issue 3/2005

Modern Rheumatology 3/2005 Go to the issue

REVIEW ARTICLE

Glucocorticoid-induced osteoporosis: skeletal manifestations of glucocorticoid use and 2004 Japanese Society for Bone and Mineral Research-proposed guidelines for its management

CASE REPORT

Two cases of cervical abscess in rheumatoid arthritis patients

ORIGINAL ARTICLE

Analysis for the major contributor of collagenase to the primary cleavage of type II collagens in cartilage degradation

CASE REPORT

A patient with symptomatic osteomalacia associated with Fanconi syndrome

LETTER

A lupus-like butterfly rash following infliximab therapy

CASE REPORT

A case of Vogt-Koyanagi-Harada disease that developed relapsing polychondritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits